Why This Condition Matters for Mothers and Babies
Gestational diabetes mellitus (GDM) is diabetes that shows up during pregnancy. It usually goes away after the baby is born. But while it lasts, it can cause serious problems.
High blood sugar can make babies grow too large. That leads to difficult deliveries and sometimes emergency C-sections. Babies born to mothers with untreated GDM are also more likely to have low blood sugar right after birth. Later in life, they face higher risks of obesity and type 2 diabetes.
For mothers, GDM increases the risk of developing type 2 diabetes down the road. It also raises the chance of having pregnancy complications like high blood pressure.
In Africa, where healthcare resources are often stretched thin, catching and treating GDM early can make a huge difference. But the first problem is knowing how many women actually have it.
The Numbers Tell a Complicated Story
Researchers pulled together data from 44 prevalence studies across Africa. When they combined the numbers, the average rate of GDM came out to 12.62 percent.
But here is where it gets tricky. That average hides a lot of variation.
Some studies found GDM rates as low as 0.7 percent. Others found rates as high as 45.9 percent. That is an enormous range. It tells you that something is off with how different places test for the condition.
The researchers used a statistical tool called a prediction interval. It showed that in any given African setting, the true GDM rate could be anywhere from 1.18 percent to 33.5 percent. That is not a useful number for making policy decisions.
This wide gap means many women are likely being missed.
What Makes Some Women More at Risk
The study identified several factors that raise a woman's chances of developing GDM. These include being older during pregnancy, having a higher body mass index, having a family history of diabetes, and having had pregnancy complications before.
These risk factors are similar to what doctors see in other parts of the world. But the way African countries screen for GDM is all over the map.
Some clinics use the older two-step testing method. Others have switched to the newer one-step test using 75 grams of glucose. Some use the IADPSG criteria from 2013. Others use older standards. This inconsistency makes it nearly impossible to compare rates across countries or track whether things are improving.
The Research Landscape Has Gaps
The study also looked at how much research on GDM is happening in Africa. The good news is that publication rates have been rising over time. The quality of studies has also been getting better.
The bad news is that most research comes from just a handful of countries. Regional collaboration is minimal. And very few studies focus on health systems or how to actually implement screening programs in real-world clinics.
Think of it this way. Researchers know a lot about the biology of GDM. They know less about how to test for it effectively in a busy clinic in rural Kenya or a crowded hospital in Lagos. That implementation gap is where the real work needs to happen.
What This Means for Pregnant Women
If you are pregnant or planning to become pregnant in Africa, this study is a reminder to talk to your doctor about GDM screening. The condition often has no symptoms. You cannot feel high blood sugar the way you feel a headache or a fever.
The standard test involves drinking a sugary solution and having your blood drawn an hour or two later. It is simple and safe. And catching GDM early means you can manage it with diet, exercise, and sometimes medication.
The researchers behind this study call for stronger regional collaboration and more consistent screening guidelines. They want African countries to adopt a standard testing method so that every woman gets the same chance at diagnosis.
The Catch
This study has limits. The data came from published research, which may not reflect what happens in clinics that never report their numbers. The variation between studies was extremely high, which makes the overall average less reliable.
Also, the study did not track what happened to the women after their pregnancies. It cannot tell us how many went on to develop type 2 diabetes or how many babies had complications.
What Happens Next
The researchers recommend that African countries work together to standardize how they screen for GDM. They also call for more research on how to integrate screening into existing maternal health programs.
Right now, there is no single set of guidelines that all African nations follow. That makes it hard to know the true scope of the problem. Until that changes, many women will continue to go undiagnosed.
The good news is that awareness is growing. More studies are being published. More doctors are paying attention. And with better collaboration across the continent, the next set of numbers may tell a clearer story.
